Label Value
DOI 10.1038/bjc.2017.234
TITLE First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial
TYPE article
Service Status Date Last Checked
Scopus Yes 2018-02-12T10:48:40.396081
Web of Science Yes 2018-04-08T07:39:18.024670
Compendex No 2019-12-19T07:08:12.566127